Abstract
We have investigated the financial costs of attempts to optimise blood pressure control in patients referred to our blood pressure clinic. At first referral, the average blood pressure in the 262 patients studied were 167/97 mmHg and the monthly costs of the antihypertensive drugs was £23.44. After 1 year of clinic attendance, the blood pressure was reduced to 149/87 mmHg, and the average drug costs had risen to £30.68. For drug expenditure alone, the cost of reducing systolic blood pressure by 1 mmHg was £0.36p (Euro 0.55, USD 0.55) and for diastolic blood pressure the cost-was £0.72p (Euro 1.12, USD 1.13).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Colhoun HM, Dong W, Poulter NR . Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998; 16: 747–752.
Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.
Sever PS et al. Management guidelines in essential hypertension: report of the Second working party of the British Hypertension Society. BMJ 1993; 306: 983–987.
Ramsay LE et al. British Hypertension Society Guidelines for hypertension management 1999—summary. BMJ 1999; 319: 630–635.
Ramsay LE et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569–592.
Bakris GL et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646–661.
Lip GYH, Beevers M, Beevers DG . The Birmingham Hypertension Square for the optimum choice of add-in drugs in the management of resitant hypertension. J Hum Hypertens 1998; 12: 761–763.
Kawachi I, Malcolm LA . The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal. J Hypertens 1991; 9: 199–208.
Osbourne VL, Beevers DG . A comparison of hospital and general practice blood pressure readings using a shared-care record card. J Roy Coll Gen Pract 1981; 31: 345–350.
Du X et al. Case–control study of stroke and the quality of hypertension control in North West England. BMJ 1997; 314: 272–276.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shiner, T., Simons, L., Parkinson, H. et al. The financial cost of optimising blood pressure control. J Hum Hypertens 19, 83–84 (2005). https://doi.org/10.1038/sj.jhh.1001778
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.jhh.1001778
Keywords
This article is cited by
-
Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study
BMC Cardiovascular Disorders (2019)
-
Characteristics of the patients referred to a Hypertension Unit between 1989 and 2003
Journal of Human Hypertension (2008)


